Classes
Publications
- Alirocumab, Praluent(R) in the light of studies2016 | First Faculty of Medicine
- Dual antiagregant therapy, indication and risk in elderly patient2012 | First Faculty of Medicine
- Combo therapy for reaching of LDL-C target2012 | First Faculty of Medicine
- Rosiglitazone little different: a view of the preventive cardiology2008 | First Faculty of Medicine
- Regional differences in physicians' behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE study2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Jistoty a nejistoty na křižovatkách současné medicíny2023 | First Faculty of Medicine
- Slibný perorální inhibitor PCSK9 ve vývoji2023 | First Faculty of Medicine
- Internista2023 | First Faculty of Medicine
- Vitamin B12 deficiency: a continent hidden from the eyes of diabetologists2023 | First Faculty of Medicine
- Expert opinion on the cooperation of diabetologists and internists with nephrologists in the care of patients with chronic kidney diseases +12022 | First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University
Loading network view...